EN
HI
Marksans Pharma Share price
MARKSANS
184.28
0.03 (0.02%)NSE
BSE
Last updated on 19 Aug, 2025 | 15:56 IST
BUYSELL
Today's High
186.00
Today's Low
181.83
52 Week Low
171.00
52 Week High
358.70
The current prices are delayed, login to your account for live prices
LoginMarksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
10.33 L
Market Cap
8353.20 CR
LTQ@LTP
100@184.28
ATP
183.65
Var Margin
24.17 %
Circuit Range
147.4-221.1
Delivery %
40.33 %
Value
18.96 CR
ASM/GSM
No
Market Lot
1
Marksans Pharma Corporate Actions
| Date | Agenda | |
|---|---|---|
| 2025-08-12 | Quarterly Results | |
| 2025-05-19 | Audited Results & Final Dividend | |
| Date | Record Date | ||
|---|---|---|---|
 | |||
Marksans Pharma News
Marksans Pharma stock skyrockets 13% on strong all-round Q1 earnings show
Aug 14 2024 12:31:54
Read More
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Mr. Mark Saldanha | Chairman & Managing Director |
| Mrs. Sandra Saldanha | Whole Time Director |
| Mr. Varddhman V Jain | Whole Time Director |
| Dr. Sunny Sharma | Non Executive Director |
| Mr. Srinivas Mishra | Independent Director |
Marksans Pharma Similar Stocks
Jupiter Life Line Hospitals Ltd.
1422.00
1.00 (0.07%)
Healthcare Global Enterprises Ltd.
664.50
-3.95 (0.59%)
Shilpa Medicare Ltd.
867.80
-15.35 (1.74%)
Procter & Gamble Health Ltd.
6291.00
67.50 (1.08%)
Strides Pharma Science Ltd.
869.45
-32.10 (3.56%)
FDC Ltd.
478.20
1.85 (0.39%)
Akums Drugs & Pharmaceuticals Ltd.
479.40
4.90 (1.03%)
Thyrocare Technologies Ltd.
1385.80
-14.10 (1.01%)
Yatharth Hospital & Trauma Care Services Ltd.
713.75
4.65 (0.66%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 184.28 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 23.83. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 3.3. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 32.96 & 3.72 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 8353.20 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 358.70 & 171.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.